Haegarda
Payments companies reported to CMS as associated with Haegarda. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Haegarda, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Haegarda
These are the largest totals companies reported as associated with Haegarda. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $120,548.76 |
| Cristine Radojicic | Durham, NC | Allergy & Immunology | $80,207.00 |
| William Lumry | Dallas, TX | $26,448.90 | |
| Michael Manning | Scottsdale, AZ | Allergy & Immunology | $19,866.39 |
| Huamin Li | Wheaton, MD | Allergy | $18,595.05 |
| John Anderson | Homewood, AL | Allergy & Immunology | $17,357.28 |
| Allen Kaplan | North Charleston, SC | Allergy & Immunology | $12,893.90 |
| Jay Kashkin | Fair Lawn, NJ | Allergy | $9,813.76 |
| Priya Bansal | Saint Charles, IL | Allergy & Immunology | $8,752.57 |
| Autumn Burnette | Washington, DC | Allergy & Immunology (Internal Medicine) | $8,331.27 |
Prescribed Haegarda?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.